The following outlines the policy for sorting or analyzing live primary human cells, potentially infectious agents, cells infected with replication incompetent virus, or cells from animals previously exposed to infectious agent using the FACS Fusion or Aurora CS.

Flow cytometry instruments that use jet-in-air fluidics produce aerosols, especially when sorting. These aerosols may contain infectious agents, such as hepatitis or HIV, when sourced from live human tissue such as PBLs or bone marrow. In addition, sorting known infectious agents such as attenuated tuberculosis bacteria or cells transfected or transformed with infectious agents such as Epstein-Barr Virus also pose a risk from aerosol exposure. Since this aerosol is under pressure, potential for infectivity is theoretically much higher than incidental exposure. In order to protect our instrument operators when sorting or analyzing potentially infectious samples, we are asking all labs that use the facility to follow these guidelines.

Prior approval for using a cell sorter (FACS Fusion, Aurora CS) to sort or analyze live primary human samples, cells from animals previously exposed to an infectious agent, or cultured cells exposed to potentially infectious agents should be obtained from the director of the facility, Dr. Zuhair Ballas. Cells transformed with BSL-2 replication incompetent virus do not need pre-approval from Dr. Ballas before sorting.

The Environmental Health and Safety Office (EHS) is requiring the facility to obtain a copy of the primary investigator's approved rDNA registration documentation before sorting cell samples transfected with rDNA.  The documentation should include a list of vectors showing the biosafety level of each. The purpose of this documentation is to help the facility determine the biosafety level of the cells. The cell sorter can then be properly configured for biohazard containment and appropriate personal protection equipment worn by facility personnel. Please provide the requested documentation to Heath Vignes (heath-vignes@uiowa.edu), Michael Shey (michael-shey@uiowa.edu) or Tom Kaufman (thomas-kaufman@uiowa.edu) in electronic format (PDF) by email to before coming to the facility for the cell sorting appointment.

Live primary human samples can be sorted using the Becton Dickinson FACS Fusion or Cytek Aurora CS which utilize biosafety cabinets to isolate the instrument operator from potential exposure to aerosols.

The facility cannot sort samples that have been exposed to BLS-3 agents or are considered BSL-3.

Included in the cell sorter reservation process is a Risk Factor form that will be filled out by the investigator for each new patient, potentially infectious agent, cells infected with replication incompetent virus, or cells from animals previously exposed to an infectious agent. This includes "normal" control subjects.

When sorting live primary human samples, a diagnosis for the person from whom the sample was obtained must be included on the risk factor form. This will help the facility assess the biosafety level of the samples.  The facility cannot sort samples from patients known to be infected with the following infectious agents or any other agent that is considered BSL-3.

  • HIV-I/II
  • HCV
  • HBV
  • HTLV I/II

When scheduling cell sorter time (sorting or analysis) for live human samples, potentially infectious agents, cells infected with replication incompetent virus, or cells from animals previously exposed to an infectious agent, post sort decontamination time will be added to the schedule automatically by the online reservation system. Charges for this time will be assessed at the regular charge rate.

Live human samples, potentially infectious agents, cells infected with replication incompetent virus, or cells from animals previously exposed to an infectious agent that are prepared for analysis only, will be run on the Cytek Aurora or BD LSR II which do not produce aerosols. The facility must be informed that these samples will be run live via the online reservation system, but will NOT require infectious disease testing or completion of a Risk Factor form. For fluorochrome combinations that require analysis, but not sorting, using the Becton Dickinson FACS Fusion or Cytek Aurora CS (cell sorters), all of the above guidelines must be followed.